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The testicular vasculature forms a complex network, providing oxygenation, micronutrients, and
waste clearance from the testis. The vasculature is also instrumental to testis function because it
is both the route by which gonadotropins are delivered to the testis and by which T is transported
away to target organs. Whether Sertoli cells play a role in regulating the testicular vasculature in
postnatal life has never been unequivocally demonstrated. In this study we used models of acute
Sertoli cell ablation and acute germ cell ablation to address whether Sertoli cells actively influence
vascular structure and function in the adult testis. Our findings suggest that Sertoli cells play a key
role in supporting the structure of the testicular vasculature. Ablating Sertoli cells (and germ cells)
or germ cells alone results in a similar reduction in testis size, yet only the specific loss of Sertoli cells
leads to a reduction in total intratesticular vascular volume, the number of vascular branches, and
the numbers of small microvessels; loss of germ cells alone has no effect on the testicular vasculature.
These perturbations to the testicular vasculature leads to a reduction in fluid exchange between the
vasculature and testicular interstitium, which reduces gonadotropin-stimulated circulating T concen-
trations, indicative of reduced Leydig cell stimulation and/or reduced secretion of T into the vascula-
ture. These findings describe a new paradigm by which the transport of hormones and other factors
intoandoutof thetestismaybe influencedbySertoli cellsandhighlights thesecellsaspotential targets
for enhancing this endocrine relationship. (Endocrinology 157: 2479–2488, 2016)
The testicular vasculature forms a complex capillarybed, interdigitating between the seminiferous tubules
to provide oxygenation, delivery of micronutrients, and
clearance of waste from the testis. Impairment of the testic-
ular vasculature, for example, the reduction in venousdrain-
age observed in cases of varicocele, causes intratesticular
hypoxia and germ cell apoptosis (1). The vasculature is also
instrumental to the endocrine functionof the testis because it
is theroutebywhichpituitarygonadotropinsaredeliveredto
the testis to support T production and spermatogenesis (2).
Conversely,alongsidethe lymphaticsystem,thevascularsys-
tem is important for transport of T to other body systems; a
reduced testis and vascular volume is associated with a re-
duction in circulating T concentrations (3).
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Our understanding of the mechanisms by which the
testis controls local vascular function in adulthood is ex-
tremely limited. There is some evidence that testicular
mast cells can influence vascular blood flow through re-
lease of 5-hydroxytryptamine (4), but perhaps the most
well-studied factor influencing testicular vascular func-
tion is T. T is a well-established regulator of testicular
vasomotion (rhythmical contraction and relaxation of
blood vessels, independent of heartbeat) (5, 6) via direct
T-mediated activation of the androgen receptor in smooth
muscle cells of the testicular vasculature (7).
Speculation that Sertoli cells may influence the testic-
ular vasculature is supportedby some indirect evidence (5)
and invitro studies (8), but confirmationofadirect role for
Sertoli cells in the regulation of the testicular vasculature
in vivo has never been demonstrated unequivocally. Re-
centlywedeveloped auniquemodel system that uses diph-
theria toxin to specifically and acutely ablate Sertoli cells
from the testis (9, 10). This model has revealed several
important, yet previously unknown, roles that Sertoli cells
play in neonatal and adult life (reviewed in reference 11).
In this study we used models of acute Sertoli cell abla-
tion and acute germ cell ablation, to address whether Ser-
toli cells actively influence vascular function in the adult
testis.Our findings suggest that Sertoli cells play a key role
in supporting the structure of the testicular vasculature
and describe a new paradigm by which the transport of
hormones and other factors into and out of the testis can
be influenced by Sertoli cells and highlights these cells as
potential targets for enhancing this endocrine
relationship.
Materials and Methods
Ethics statement
Mice were housed and bred under standard conditions of
care. Experiments passed local ethical review and were con-
ducted with licensed permission under the UK Animal Scientific
Procedures Act (1986) (Home Office license number PPL
60/4200).
Mouse tissue collection
Animalswith selective Sertoli cell ablation (9, 10) or germ cell
ablation (12) were generated and tissue collected, as previously
described.
Testis dissociation and xenografting
Testis dissociation into a single cell suspension, pelleting in
Matrigel, and subcutaneous xenografting under the back skin of
castrated male CD1 nude mice were completed as previously
described (13). Xenografts were retrieved 4 weeks later,
weighed, and fixed in Bouin’s solution for 2 hours.
Resin perfusion
Mice were culled using a terminal dose of sodium pentobar-
bital (150 mg/kg, ip). Anterograde perfusion fixation of the vas-
culature was achieved via the left ventricle. Heparinized PBS
(heparin, 20U/mL)was infused at 6mL/min for 2minutes. Low-
viscosity resin (10 mL; Microfil MV-122; Flow Tech Inc) was
prepared according to the manufacturer’s instructions and then
infused via the left ventricle. Tissues were fixed in
paraformaldehyde.
Optical projection tomography (OPT) and
microcomputed tomography (CT) scanning of
resin cast testes
Resin cast testes were processed for OPT as previously de-
scribed (14) with a final isotropic voxel size of 8.07  8.07 
8.07m3. ForCT, sampleswere placed in a Skyscan1172CT
(Bruker) as previously described (15) and scanned with the fol-
lowing parameters: voxel resolution 3.44 m, voltage 41 kV,
current 240 A, exposure 1767 msec, and a 0.5-mm aluminum
filter. The reconstructed datawere processed byCTvox software
(Skyscan) and quantified by CTAn software (Skyscan). During
the scanning and reconstruction process, the identity of the sam-
ples was blinded.
Vessel density quantification and image analysis
procedure
Vessel densitywasquantifiedusing ImageProplus7.0on tiled
images in which vessels were identified by vascular marker Von
Willebrand factor (VWF; red). Images were binarized, with the
vessels in white and the background in black. The vessel density
was reported relative to the xenograft area. A vessel analysis was
performed on three-dimensional (3D)OPT andCT volumes in
the software package (Fiji) (16) using the Analyze Skeleton pl-
ugin (17).
RNA isolation and real-time PCR
Real-time PCR and analysis was carried out as previously
described and normalized against an external standard (lu-
ciferase) (10). The primers used are described in Supplemental
Table 1.
Histological analysis
Hematoxylin and eosin staining and immunofluorescent lo-
calization was carried out as previously described (10). The pri-
mary antibodies used were CD31 (Abcam Ltd; ab28364), VWF
(Dako; A0082), cleaved caspase-3 (Cell Signaling (NEB); num-
ber 9661), DDX4 (DEAD-box helicase 4) (Abcam Ltd;
ab13840), and SOX9 (Sex Determining Region Y-Box 9) (Mil-
lipore; ab5535).
Vasculature-testis fluid exchange
Animals with selective Sertoli cell or germ cell ablation and
their littermate controls were iv injectedwith 200L Evans Blue
dye (0.5% in PBS) 30 minutes prior to culling. Tissue was pro-
cessed and extravasationquantified as previously described (18).
Cell preparation
Testicular cell suspensions were prepared from three to five
adult animals per group as described (19) and incubated with
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recombinant human LH (109 M) (LH; MerckSerono) (20).
To normalize the data for the Leydig cell number, results were
determined relative to the stable expression of Hsd3b1 tran-
script levels measured in nonincubated cell aliquots (21–23).
Each experiment was performed in triplicate on three separate
occasions, and the overall data from the three experiments are
reported.
T quantification
T levels were determined as previously described (10). One
cohort of animals received a single ip injection of 20 IU human
chorionic gonadotropin (hCG) (Pregnyl; Organon) 16 hours
prior to tissue collection.
Statistical analysis and image handling
Data (mean SEM) were analyzed using a Student t test or
an ANOVA as appropriate) using GraphPad Prism (version 6;
GraphPad Software Inc) or Minitab (version 15Minitab Inc).
When required, datawere normalized by box-cox or log trans-
formation. Images were compiled as previously described (9).
Results
Vascular analysis after induced cell ablation
Amh-Cre/;iDTR/ mice were generated, and the
specificity and efficacy of Sertoli cell ablation demon-
strated, as previously described (9–11). Briefly, an injec-
tion of 100 ng of diphtheria toxin (DTX) induces apopto-
sis of the Sertoli cell population within 1 day, whereas an
injection of a vehicle control has no effect. In this study,
day 50 adult males were injected with 100 ng DTX and
tissue collected 7 or 30 days later. Because the loss of
Sertoli cells also leads to a complete loss of the germ cell
population within 30 days (9), we replicated all analyses
in a cohort of mice treated with busulfan, which specifi-
cally removes only the germ cell population (12). This
cohort not only provided a comparator between impacts
of germ cell loss vs Sertoli cell loss, but because both treat-
ment groups exhibit the same reduction in testis volume,
Figure 1. Vascular analysis after Sertoli cell-induced cell ablation and germ cell-induced cell ablation. Adult testes from Amh-Cre;iDTR mice
treated with DTX and collected 30 days after Sertoli cell ablation (A) and germ cell-ablated animal (B) were resin casted, scanned by CT or OPT,
and 3D images reconstructed. Scale bar, 0.1 cm. C and D, The contralateral testes were processed for histology and the testicular gross histology
revealed the presence of functional vessels (arrowheads) Scale bar, 100 m. Total testis volume was significantly reduced (E) 30 days after Sertoli
cell ablation or germ cell ablation and total vascular volume was reduced (G) after Sertoli cell ablation (F) but remained unchanged after germ cell
ablation (H). (t test, n  3–6). **, P  .05; ***, P  .001; ****, P  .0001. bus, injected with busulfan; DTX, injected with toxin; post inj., post
injection.
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this also acted as a control for any overall change in organ
size, which is known to influence the total volume of in-
traorgan vascularization in a predictable manner (24).
Micewere perfusedwith a lead radioopaque resin prior
to tissue collection. Testes were scanned byCT andOPT
toprovidehigh-resolution3Dreconstructions (Figure1,A
and B, and Supplemental Figure 1A). Hematoxylin and
eosin staining of testicular tissue sections from contralat-
eral testes confirmed Sertoli cell ablation in DTX-treated
testes and germ cell ablation in the busulfan-treated testis
and confirmed that at both 7 days or 30 days after the
ablation, the grossmorphologyof functional bloodvessels
was intact and that all blood vessels contained resin (Fig-
ure 1,CandD, arrowheads, and Supplemental Figure 1B).
Importantly, despite the loss of Sertoli and/or germ cells,
seminiferous tubules, although reduced in diameter in
both groups, remained structurally intact in all samples
(ie, retaining a defined basement membrane and peritu-
bular cells,whichcontinue to separate the tubules fromthe
interstitium), ensuring that gross testicular architecture
was maintained.
Total vascular volume is reduced after Sertoli cell,
but not germ cell, ablation
Quantitative analysis of OPT and CT images showed
that testicular volume was significantly reduced in the 7-
(P .01) and30-day (P .0001) Sertoli cell-ablated testes
and 30-day germ cell-ablated testes (Figure 1, E–G, and
Supplemental Figure 1C), consistent with previous obser-
vations (9, 12). Total vascular volume was unchanged in
7-day Sertoli cell-ablated testes and 30-day germ cell-ab-
lated testes but was significantly decreased 30 days after
Sertoli cell ablation P  .001, (Figure 1, F–H, and Sup-
plemental Figure 1D), suggesting Sertoli cells, but not
germcells, play an important role in the long-term support
of the testicular vascular network.
To determine how the vascular volume becomes re-
duced by 30 days after Sertoli cell ablation, we examined
the testes 1, 3, 7, and 30 days after Sertoli cell ablation for
evidence of increased cell apoptosis (cleaved caspase-3 im-
munolocalization) in vessels (immunostained with endo-
thelial marker VWF). Although Sertoli cell and germ cell
apoptosiswas observedwithin the seminiferous tubules at
3 and 7 days after Sertoli cell ablation, no evidence of
endothelial cell apoptosis was found, suggesting any vas-
cular apoptosis occurs between 7 days and 30 days after
Sertoli cell ablation (Supplemental Figure 2) and that the
reduction in vascular volume observed in response to Ser-
toli cell loss therefore occurs over an extended period of
several weeks.
Sertoli cells increase testicular microvessel density
in a xenograft model
To further assess the relationship between Sertoli cells
and vascular development and retention, we used a well-
developed model of testis dissociation and xenografting
Figure 2. Sertoli cells increase testicular microvessel density in a
xenograft model. Control and Sertoli cell-ablated testes were
dissociated to a single-cell suspension, pelleted in matrigel, and
xenografted under the skin of nude mice. A, Germ cell marker DDX4
showed few germ cells are present in the xenografts. Scale bar, 100
m. B, Sertoli cell marker SOX9 and vascular marker VWF
coimmunolocalization showed that Sertoli cells are required for
reformation of seminiferous tubules (delimited by the dotted lines) and
confirmed the presence of microvessels within the graft, respectively
(white arrows). Scale bar, 100 m. C, Microvessel density per
xenograft area was quantified histologically using the specific
endothelial marker VWF. This revealed a significant decrease in
microvessel density in xenografts lacking Sertoli cells (t test, n  3–4).
*, P  .05). ctr, control; dtx, injected with DTX.
2482 Rebourcet et al Sertoli Cells Modulate Testis Vasculature Endocrinology, June 2016, 157(6):2479–2488
The Endocrine Society. Downloaded from press.endocrine.org by [${individualUser.displayName}] on 17 June 2016. at 02:18 For personal use only. No other uses without permission. . All rights reserved.
(10, 25, 26). Isolated control testes and Sertoli cell-ablated
testes were made into single-cell suspensions 7 days after
Sertoli cell ablation (to control for any difference in tes-
ticular architecture), pelleted inMatrigel, andxenografted
under the skin of nudemice; grafts were collected 4 weeks
later. Consistent with our own and other previous pub-
lished studies (10, 13, 26), germ cell survival was minimal
in all xenografts (Figure 2A). This negated any potential
impact of germ cells on vascularization and permitted us
to directly assess the impact of Sertoli cell presence or
absence on microvessel formation. Microvessels were ap-
parent (immunostaining for VWF) in xenografts both
with or without Sertoli cells (Figure 2B), but quantifica-
tion of themicrovessel density demonstrated that the pres-
ence of Sertoli cells significantly increased the numbers of
microvessels within the graft (Figure 2C). This suggests
that Sertoli cells positively influence the numbers of mi-
crovessels in their local environment.
Sertoli cell ablation, but not germ cell ablation,
reduces vascular-testis fluid exchange
We next assayed for functional impacts by examining
fluid exchange between the vascular system and the testis.
We quantified fluid flow into the testis indirectly using the
well-established ability of Evans blue dye to bind albumin.
The amount of extravasation of albumin-bound dye from
blood vessels into the interstitium directly correlates with
the total vascular permeability of a tissue (18). BecauseLH
is known to increase vascular-tissue fluid exchange (28),
we first validated this approach on a cohort of animals
treated with the alternative LHCGR (luteinizing hor-
mone/choriogonadotropin receptor) agonist, hCG, 16
hours prior to collection. As expected, fluid flow into the
testis was significantly increased in hCG-treated animals
comparedwithunstimulated controls, confirming that the
methodwill detect changes in fluid exchange (Supplemen-
tal Figure 3A). To examine the role of the Sertoli cells in
regulating this, the fluid exchangewasmeasured in Sertoli
cell-ablated mice (30 d after Sertoli cell ablation; with-
out hCG stimulation) and was shown to be significantly
reduced (P .01) (Figure 3). In contrast, vascular perme-
Figure 3. Sertoli cell ablation, but not germ cell ablation, reduces the
vascular-testis fluid exchange. Vascular-testis fluid exchange was
measured by quantification of Evans blue extravasation. The OD read
at 620 nm was converted to nanograms of dye extravasated per
milligram of tissue. Extravasation after busulfan treatment was
comparable between vehicle and germ cell-depleted testes. However,
in the absence of Sertoli cells, the vascular extravasation was
significantly decreased (t test, n  3–6). **, P  .01. Bus, injected
with busulfan; Vehicle Bus, vehicle for the Bus group; vehicle dtx,
vehicle for the DTX group; dtx, injected with DTX.
Figure 4. Normal vascular branching and number of microvessels in the adult testis are Sertoli cell dependent. The total number of vascular
branches (A) and the total number of vascular branches per testis volume (B) were significantly decreased 30 days after Sertoli cell ablation, but the
mean average branch length (C) did not change (t test, n  3–6). ***, P  .001. All three parameters remained unchanged after germ cell
ablation (D–F). The number of microvessels with a diameter less than 60 m2 was significantly reduced in Sertoli cell-ablated testes when
compared with untreated controls (G) (two way ANOVA with a Tukey post hoc test, n  3–6). ****, P  .0001. However, normal vessel
distribution was retained after germ cell ablation when compared with untreated controls (H). Bus, busulfan.
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Figure 5. Endothelial markers expression is reduced after Sertoli cell, but not germ cell, ablation. Established endothelial cell markers VWF and
CD31 were confirmed to be restricted to endothelial cells of the testicular vasculature (A). Scale bar, 100 m. Expression of both endothelial
markers (B) Cd31 and (C) Cdh5 did not vary 7 days after Sertoli cell ablation or after germ cell ablation but did exhibit a significant reduction 30
days after Sertoli cell ablation (one way ANOVA, n  5–9 on DTX samples and t test on bus samples). *, P  .05; ***, P  .001). Bus, injected
with busulfan; dtx, injected with DTX; post inj., after injection.
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abilitywas unaffected after germcell ablation (30dafter
germ cell ablation; without hCG stimulation) despite a
similar reduction in testis weight (Figure 3). Heart and
lung control tissues showed no difference in fluid ex-
change, confirming that the observed reduction in fluid
flow in Sertoli cell-ablated testis of DTX-treatedmice, is a
direct result of the removal of Sertoli cells from the testis
(Supplemental Figure 3, B and C).
Normal vascular branching in the adult testis is
Sertoli cell dependent
To establish the anatomical mechanism by which fluid
exchange is impaired, we characterized the branching of
the intratesticular vascular network. The total number of
vascular branches (junctions between vessels), the number
of branches corrected for total testis volume, and themean
average branch length were all unchanged 7 days after
Sertoli cell ablation (Supplemental Figure 4, A–C). How-
ever, at 30 days after the Sertoli cell ablation, although
there was again no change in branch length, we did ob-
serve a significant reduction in the total number of vas-
cular branches, which was independent of total testis vol-
ume (Figure 4, A–C). Importantly, we did not observe a
similar reduction in total branch number in testes 30 days
after germ cell ablation (Supplemental Figure 4, D–F),
which strongly indicates that the reduction in total branch
numbers is a response to the absence of Sertoli cells.
Microvessel number in the adult testis is Sertoli
cell dependent
To assess the impact of Sertoli cell ablation on vessel
size distribution, vessel size was determined on central
transverse sections derived from each 3D reconstructed
image. At 7 days after Sertoli cell ablation, vessel size dis-
tribution did not differ between treated and control ani-
mals (Supplemental Figure 4D). At 30 days after Sertoli
cell ablation, however, although all larger vessels showed
no difference between groups,we did observe a significant
reduction in microvessels with a cross-sectional area less
than 60 m2 (Figure 4G). This was not seen in testes from
the 30-day postgerm cell ablation, which showed no
change in vessel number of any size (Supplemental Figure
4H). The reduction in microvessel numbers observed 30
days after the Sertoli cell ablation was supported by a
significant reduction in the gene expression of the con-
firmed endothelial cell-specificmarkersCD31 (Figure 5A)
andCDH5only in this group (Figure5,BandC).Together
these results indicate that the retention of microvessels
with a diameter less than 60 m2 in the adult testis is also
Sertoli cell dependent.
Reduced microvessel number explains reduced
fluid exchange after Sertoli cell ablation
To complete this analysis, we then compared the re-
duction in microvessel number to the observed reduction
Figure 6. Reduced fluid exchange impairs stimulation of Leydig cell T
production. Leydig cell response to in vivo gonadotropin (hCG)
stimulation was assessed 30 days after Sertoli cell ablation. Both total
circulating T (A) (two way ANOVA, n  5–20, ****, P  .0001) and
circulating T relative to total Leydig cell number (B) (two way ANOVA,
n  5–20, *, P  .05, ****, P  .0001) were significantly reduced. C,
Isolated testicular cells were incubated under basal conditions or in the
presence of LH (109 M) and T production analyzed. Results show the
accumulated data (mean  SEM) from three experiments normalized
to the maximum control T level in each experiment. Each experiment
was in triplicate and data were analyzed by a three-way ANOVA
(experiment, LH and DTX were factors). This analysis showed a
significant overall stimulatory effect of DTX, and post hoc testing
showed that the effect of DTX was significant in each individual
experiment.
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in fluid flow into the testicular interstitium (Supplemental
Figure 5). Correcting for the reduction in microvessel
number normalizes the difference in fluid flow observed
between Sertoli cell-ablated and control testes, suggesting
that the reduction in numbers ofmicrovessels explainsmost,
ifnotall,of thedifference in fluid flowinto the testisobserved
between the two groups (Supplemental Figure 5).
Reduced fluid exchange impairs the stimulation of
Leydig cell T production
The significant reduction in fluid exchange could affect
T production by the Leydig cells through reducing LH
stimulation of these cells. To address this possibility, we
injected control or Sertoli cell-ablated animals (30 d after
the DTX injection) with hCG (another LHCGR agonist)
and then measured circulating T concentrations 16 hours
later. Sertoli cell ablation caused a significant reduction in
hCG-stimulated T concentrations (Figure 6A), which was
not completely explained by correcting for the reduction
in Leydig cell numbers observed in this model (9) (Figure
6B). This raises the possibility that Leydig cells in the Ser-
toli cell-ablated mice are being understimulated by the
circulating hCG due to compromised fluid flow. Alterna-
tively, it is possible that Leydig cells in Sertoli cell-ablated
testes are less active and do not respond as well to trophic
stimulation or that reduced fluid exchange reduces secre-
tion of T into the vasculature. To examine this further, we
isolated Leydig cells from control and Sertoli cell-ablated
testes and stimulated them directly in vitro with LH (Fig-
ure 6C). Isolated Leydig cells fromboth groups responded
to LH treatment. Leydig cells from the Sertoli cell-ablated
testis in fact showed a hyperactive response to LH.
Discussion
The definition of an endocrine gland is that it secretes its
product into the vascular system, leading to a subsequent
action at target organs. In the testis, which both receives
endocrine stimulation (primarily, but not exclusively, by
gonadotropins) and secretes androgens into the circula-
tion in response to this stimulation, the development, in-
tegrity, and function of the vascular network is essential.
Despite the importance of the vasculature, the factors that
control vascular integrity and function in the adult testis
have remained largely unknown. In contrast, the role of
Sertoli cells in promoting many key aspects of testis de-
velopment and function has expanded in recent times (9–
11). In this study,wenowdemonstrate that Sertoli cells are
also essential for normal regulation of the testicular vas-
culature. Specific ablation of Sertoli cells in vivo leads to
a reduction in total intratesticular vascular volume, the
number of vascular branches, and the numbers of small
microvessels. Absence of Sertoli cells in a testis xenograft
model also reduces microvessel numbers within the graft.
Together these observations support an active role for Ser-
toli cells in the development and maintenance of the tes-
ticular microvessel network.
Perturbations to the vascular network after Sertoli cell
ablation leads to a reduced capacity for fluid exchange, as
indicated by a reduction in gonadotropin-stimulated cir-
culating T concentrations, despite the high steroidogenic
potential of Leydig cells in the Sertoli cell-ablated testis.
Our evidence suggests that the failure to respondnormally
to hCG when stimulated in vivo (ie, failure to increase
circulating T concentrations) is likely to be due to a re-
duction in the numbers of microvessels, the reduced num-
Table 1. Antibody Table
Peptide/Protein
Target Antigen Sequence (if Known)
Name of
Antibody
Manufacturer,
Catalog Number,
and/or Name of
Individual
Providing the
Antibody
Species Raised
(Monoclonal or
Polyclonal)
Dilution
Used
CD31 Synthetic peptide corresponding
to C terminus of mouse CD31
CD31 Abcam Ltd, ab28364 Rabbit polyclonal 1:100
VWF VWF Dako, A0082 Rabbit polyclonal 1:1500
DDX4 Synthetic peptide conjugated to
KLH derived from within residues 700
to the C terminus of human DDX4/MVH
DDX4 Abcam Ltd, ab13840 Rabbit polyclonal 1:400
Cleaved
caspase-3
Antibody detects endogenous
levels of the large fragment (17/19 kDa)
of activated caspase-3 resulting from
cleavage adjacent to Asp175
Cleaved
caspase-3
Cell Signaling (NEB),
number 9661
Rabbit polyclonal 1:500
SOX9 SOX9 Millipore,
ab5535
Rabbit polyclonal 1:4000
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bers of endothelial cells (important for transcytosis of LH/
hCG into the testis (29, 30), and, by definition, a reduced
surface area for fluid exchange (hCG in and T out). The
dual role of LH/hCG in terms of both increasing vascular
fluid exchange in the testis (Supplemental Figure 3) (28,
31) and also directly stimulating T production remain un-
derexplored. Our data suggest that the ability to enhance
fluid exchange may be an important role because hCG
treatments fail to produce the expected response in hy-
peractively primed Leydig cells present in the Sertoli cell
ablated testis; this requires further study. Together
these data suggest that Sertoli cell support for the re-
tention of testicular microvessels in the adult testis
forms a hitherto unrecognized yet key component of the
endocrine system of the testis. Importantly, our studies
also show that the germ cells have little influence over
the testicular vasculature.
Themechanisms bywhich the Sertoli cells influence the
testicular vascular structure and function are not clear.
The most likely mechanisms are through specific Sertoli
cell-derived factors or through secondary paracrine sig-
nals arising from the Leydig cells or peritubular cells.
There is good evidence that the Leydig cells regulate tes-
ticular vasomotion through the secretion of T (6, 32),
which acts throughandrogen receptor on vascular smooth
muscle cells (33). In addition, ablation of the Leydig cells
suppresses the proliferation of endothelial cells and active
remodeling of the testicular vasculature, whereas the
transplantation of interstitial cell grafts (but not isolated
tubules) leads to development of a prominent vascular
network around the graft (34). Ablation of the Sertoli cells
leads to a 50% loss of the Leydig cell population by 30
days (9), so changes in the testicular vasculature may be a
result of lost interaction between these cell types. There is
also evidence, however, that the Sertoli cells can secrete
factors that stimulate endothelial cell proliferation (27)
and formation of capillary-like structures in vitro (8), so
further study is required to identify the underlying
mechanism.
In conclusion, the findings presented here describe a
new paradigm by which the transport of hormones and
other factors into and out of the testis is influenced by
Sertoli cells and highlights Sertoli cells as potential targets
for enhancing this endocrine relationship.
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